iRhythm Holdings (IRTC) Total Current Liabilities (2015 - 2026)
iRhythm Holdings (IRTC) posted quarterly Total Current Liabilities of $131.8 million for Q1 2026, up 18.33% year-over-year from $111.3 million in Q1 2025, and down 13.26% quarter-over-quarter from $151.9 million in Q4 2025.
iRhythm Holdings (IRTC) Total Current Liabilities (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Total Current Liabilities for 12 consecutive years, with $131.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 18.33% year-over-year to $131.8 million; the TTM figure through Mar 2026 stood at $131.8 million (up 18.33% YoY), while the FY2025 annual figure was $151.9 million, up 36.94% from the prior year.
- Total Current Liabilities fell to $131.8 million in Q1 2026 per IRTC's latest filing, from $151.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $151.9 million in Q4 2025 and bottomed at $61.8 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $103.9 million across 5 years, with a median of $100.1 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities decreased 3.56% — and 2025, when it jumped 46.76%.
- iRhythm Holdings' Total Current Liabilities stood at $89.1 million in 2022, then advanced by 20.51% to $107.4 million in 2023, then gained by 3.31% to $110.9 million in 2024, then soared by 36.94% to $151.9 million in 2025, then slipped by 13.26% to $131.8 million in 2026.
- Business Quant data shows IRTC's Total Current Liabilities at $131.8 million in Q1 2026, $151.9 million in Q4 2025, and $146.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | iRhythm Holdings | 4.23 Bn | 3.64 Bn | 163.21 Mn | 196.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 196.10 Mn |
| Mar 31, 2026 | 131.75 Mn |
| Dec 31, 2025 | 151.89 Mn |
| Sep 30, 2025 | 146.91 Mn |
| Jun 30, 2025 | 132.21 Mn |
| Mar 31, 2025 | 111.34 Mn |
| Dec 31, 2024 | 110.92 Mn |
| Sep 30, 2024 | 100.10 Mn |
| Jun 30, 2024 | 97.90 Mn |
| Mar 31, 2024 | 96.84 Mn |
| Dec 31, 2023 | 107.37 Mn |
| Sep 30, 2023 | 102.29 Mn |
| Jun 30, 2023 | 89.41 Mn |
| Mar 31, 2023 | 81.90 Mn |
| Dec 31, 2022 | 89.10 Mn |
| Sep 30, 2022 | 83.59 Mn |
| Jun 30, 2022 | 70.42 Mn |
| Mar 31, 2022 | 61.78 Mn |
| Dec 31, 2021 | 87.85 Mn |
| Sep 30, 2021 | 82.78 Mn |